NEW 2013 WHO GUIDELINES FOR ART IN HIV
The new recommendations encourage all countries to initiate treatment in adults living with HIV when their CD4 cell count falls to 500 cells/mm³ or less – when their immune systems are still strong. The previous WHO recommendation, set in 2010, was to offer treatment at 350 CD4 cells/mm³ or less. 90% of all countries have adopted the 2010 recommendation. A few, such as Algeria,Argentina and Brazil, are already offering treatment at
The new recommendations also include providing antiretroviral therapy – irrespective of their CD4 count –
to all children with HIV under 5 years of age, all pregnant and breastfeeding women with HIV, and to all HIV-positive
partners where one partner in the relationship is uninfected. The Organization continues to recommend
that all people with HIV with active tuberculosis or with hepatitis B disease receive antiretroviral therapy.
Another new recommendation is to offer all adults starting to take ART the same daily single fixed-dose
combination pill. This combination is easier to take and safer than alternative combinations previously
recommended and can be used in adults, pregnant women,
adolescents and older children.
The recommended treatment is now a combination of three antiretroviral drugs: tenofovir and lamivudine (or
emtricitabine) and efavirenz, as a single pill, given once daily.